Phagocytosis of cancer cells induced by calreticulin on their surface has been shown to result in presentation of antigens from the cancer cell on the phagocyte together with MHCII, resulting in an adaptive immune response to the cancer (14, 15). The gene discussed is CALR; the disease is cancer.